Haemonetics (HAE) Non-Current Deferred Tax Liability (2010 - 2026)

Haemonetics' Non-Current Deferred Tax Liability history runs 17 years deep, the most recent figure standing at $38.0 million for Q1 2026.

• In Q1 2026, Non-Current Deferred Tax Liability fell 72.81% year-over-year to $38.0 million; the TTM figure through Mar 2026 stood at $38.0 million (down 72.81% YoY), while the FY2026 annual figure was $38.0 million, down 72.81% from the prior year.
• Non-Current Deferred Tax Liability was $38.0 million for Q1 2026 at Haemonetics, down from $56.0 million in the prior quarter.
• In the past five years, Non-Current Deferred Tax Liability ranged from a high of $140.0 million in Q1 2025 to a low of $26.1 million in Q1 2022.
• Historically, Non-Current Deferred Tax Liability has averaged $56.3 million across 5 years, with a median of $57.1 million in 2025.
• The sharpest annual moves came in 2023 and 2026: Non-Current Deferred Tax Liability soared 291.54% in 2023, then plunged 72.81% in 2026.
• A 5-year view of Non-Current Deferred Tax Liability shows it stood at $40.2 million in 2022, then jumped by 55.03% to $62.2 million in 2023, then retreated by 1.28% to $61.5 million in 2024, then retreated by 8.9% to $56.0 million in 2025, then slumped by 32.03% to $38.0 million in 2026.
• The last three Non-Current Deferred Tax Liability figures came in at $38.0 million (Q1 2026), $56.0 million (Q4 2025), and $58.2 million (Q3 2025), per Business Quant data.